
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+13
PRONACERA THERAPEUTICS S.L. emerges as Spin-Off from the Group of Physiology, Anatomy and Cell Biology at the University Pablo Olavide whose origins date back to 2011. It has the know-how derived from the development of patent P201331533 for international protection as Stabilizers compounds of apoptotic cells or ES2438617B1 Method for screening and/or evaluation of the effectiveness of drugs for the treatment of mitochondrial diseases and MELAS syndrome. We also have extensive experience in the study of apoptosis, mitochondrial and lysosomal diseases. PRONACERA THERAPEUTICS S.L. is a biotechnologyc company based on the talent of our young researchers as an engine for...
Biotechnology,rare diseases,fibromyalgia,diagnostic,treatments,reproduction,fiv,ar,fibromialgia,reproduccion,nutrigenética,medicina personaliza,test genéticos,análisis clinicos,cardiovascular,endometrio,fertilidad,and reproduccionasistida
Pronacera therapeutics s.l operates in the Biotechnology research industry.
Pronacera therapeutics s.l's revenue is 11m - 100m
Pronacera therapeutics s.l has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.